Alferiev, I.S.; Guerrero, D.T.; Soberman, D.; Guan, P.; Nguyen, F.; Kolla, V.; Fishbein, I.; Pressly, B.B.; Brodeur, G.M.; Chorny, M.
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models. Int. J. Mol. Sci. 2022, 23, 1752.
https://doi.org/10.3390/ijms23031752
AMA Style
Alferiev IS, Guerrero DT, Soberman D, Guan P, Nguyen F, Kolla V, Fishbein I, Pressly BB, Brodeur GM, Chorny M.
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models. International Journal of Molecular Sciences. 2022; 23(3):1752.
https://doi.org/10.3390/ijms23031752
Chicago/Turabian Style
Alferiev, Ivan S., David T. Guerrero, Danielle Soberman, Peng Guan, Ferro Nguyen, Venkatadri Kolla, Ilia Fishbein, Blake B. Pressly, Garrett M. Brodeur, and Michael Chorny.
2022. "Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models" International Journal of Molecular Sciences 23, no. 3: 1752.
https://doi.org/10.3390/ijms23031752
APA Style
Alferiev, I. S., Guerrero, D. T., Soberman, D., Guan, P., Nguyen, F., Kolla, V., Fishbein, I., Pressly, B. B., Brodeur, G. M., & Chorny, M.
(2022). Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models. International Journal of Molecular Sciences, 23(3), 1752.
https://doi.org/10.3390/ijms23031752
